Healthcare Pharmaceutical Biotech

SimiTree Appoints Drew McCartney as Executive Vice President of Behavioral Health, Signaling Deep and Lasting Commitment to the Sector

June 10, 2026 8:00 AM

SimiTree, a leading provider of consulting, technology, and outsourcing solutions for healthcare organizations, today announced the appointment of Drew McCartney as Executive Vice President of Behavioral Health. With more than 30 years of experience leading healthcare services organizations, McCartney brings unparalleled expertise in behavioral health operations, growth strategy, and value creation to SimiTree's expanding behavioral health...

Read more

Many Cancer Patients Leave Treatment Options on the Table - You Don't Have To

June 10, 2026 7:00 AM

A cancer diagnosis can hinge on a single decision: whether your treatment plan is matched to the specific biology driving your tumor. Genomate Health today launched its physician-led, AI-powered second opinion service, available via telehealth and eligible for HSA/FSA reimbursement. Genomate's AI builds a personalized model of each patient's tumor, informing medical experts of optimal treatment options, so that patients never have to wonder...

Read more

Who Does the Best Blepharoplasty in Florida?

June 10, 2026 6:00 AM

As demand for eyelid surgery continues to grow across Florida, patients are increasingly seeking surgeons who can deliver natural-looking blepharoplasty results while preserving facial harmony and expression. Among the names frequently cited in discussions about blepharoplasty is Dr. Alberico J. Sessa, founder of Sarasota Surgical Arts. Based on factors such as dual board certification, extensive surgical experience, contributions to surgeon...

Read more

Zomedica Announces "Fourth Friday at Four" Webinar on June 26, 2026: The Five Pillars of Zomedica - Framework for Clinical Value and Shareholder Returns

June 10, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, June 26 at 4:00 p.m. Eastern Time. The June program, titled "Fourth Friday at Four, The Five Pillars of Zomedica: Framework for Clinical Value...

Read more

Cantargia Announces Start of New Investigator-Initiated Lung Cancer Prevention Study

June 10, 2026 1:45 AM

Cantargia AB (Publ) (STO:CANTA) today reported that the first patient has been dosed in a Phase 2 clinical trial investigating nadunolimab in up to 59 current or previous smokers with multifocal high-risk lung nodules, and therefore at risk of developing lung cancer. The study is an investigator-led initiative in collaboration with Drs. Robert Samstein, Thomas Marron and Miriam Merad at Mount Sinai Tisch Cancer Center, New York. "Building on the...

Read more

PureVive CBD Gummies Review (2026) Top Maximum-Strength Full Spectrum Hemp Extract Gummy Brand to Use by Pure Vive CBD

June 9, 2026 7:25 PM

PureVive CBD Gummies Review 2026: What Buyers Should Know About Full Spectrum Hemp Extract Gummies Before Ordering If you've been searching for an honest, no-fluff breakdown of PureVive CBD Gummies - what's actually on the label, what the brand claims vs. what the science supports, and what you genuinely need to know before ordering - you're in exactly the right place. This guide covers everything, including a few things most CBD reviews skip...

Read more

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology

June 9, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the initiation of process development and intermediate[1] scale-up activities for A83B4C63, the Company's active pharmaceutical ingredient (API) in the Company's proprietary drug candidate, ONC010 (the "PNKP Inhibitor Technology"). This milestone marks an important step in advancing the Company's chemistry,...

Read more

Infinx Scales Governed AI Capabilities Using Microsoft Azure Across Healthcare Workflows

June 9, 2026 4:10 PM

Infinx, a provider of AI, automation, and human-driven solutions for healthcare revenue cycle management (RCM), today announced it is expanding its use of Microsoft Azure infrastructure and AI-enables cloud services, to support select AI workloads across patient access and revenue cycle workflows. Healthcare organizations are increasingly prioritizing AI capabilities that are designed to operate responsibly within operational environments, where...

Read more

FeelGood QUAD Reviews 2026: Why Men are Comparing 4-in-1 Sublingual ED Telehealth Options

June 9, 2026 3:55 PM

Important: This article is promotional content, is not medical advice, and does not guarantee prescription approval, treatment suitability, or individual results. FeelGood QUAD is a compounded prescription product requiring independent clinician review. Compounded drugs are not FDA-approved. Title Reference Notice: "4-in-1 Compounded Sublingual ED Formula" uses factual category and delivery descriptors aligned with the brand's published product...

Read more

THX Pharma, Biocodex and the Beyond Batten Disease Foundation Stand Together with the CLN3 Batten Community on International Batten Disease Awareness Day

June 9, 2026 3:00 PM

On the occasion of International Batten Disease Awareness Day happening today, THX Pharma (Theranexus), a biopharmaceutical company specializing in the development of innovative treatments for rare neurological diseases, Biocodex, an independent international pharmaceutical group and long-time pioneer in the treatment of rare pediatric diseases, and the Beyond Batten Disease Foundation (BBDF), a patient-founded non-profit dedicated to...

Read more

Gala Health HRT Review 2026: What Women Still Avoiding Hormone Therapy Based on Old FDA Warnings Should Know - $79/Month, No Insurance, Provider Details

June 9, 2026 2:55 PM

Disclaimer: This article is for informational purposes only - it's not medical advice. Hormone replacement therapy is a prescription treatment that requires evaluation by a qualified, licensed healthcare professional. Always consult a licensed clinician before starting, changing, or stopping any prescription treatment. Hormone replacement therapy is not appropriate for all patients. Eligibility is determined by a licensed provider based on...

Read more

FeelGood GLP-1 Review 2026: $149/Month Compounded Program, What FDA's June 2026 503B Proposal Changes for Buyers, and a 20-Question Enrollment Checklist

June 9, 2026 12:55 PM

Title Reference Notice: "FeelGood GLP-1" is the consumer-facing product identifier published by FeelGood Health at feelgoodmeds.com. "Advertorial Review 2026" identifies this as a sponsored advertorial. "$149/Month Brand-Stated Starting Price" reflects FeelGood's published starting price for compounded injections - actual cost may vary by dosage and program tier; verify at checkout. "20 Buyer Verification Questions" refers to the buyer checklist...

Read more

EmpoweRx Rebrands as RuraLink to Support a More Sustainable Rural Healthcare Workforce

June 9, 2026 9:58 AM

EmpoweRx, a Maine-based healthcare workforce technology company, today announced its rebrand to RuraLink, reflecting the company's continued commitment to helping healthcare organizations and healthcare professionals build stronger workforce connections across rural communities. The rebrand reflects the company's ongoing commitment to strengthening workforce access and supporting healthcare organizations serving rural and underserved...

Read more

DirectTrust(R) Launches Artificial Intelligence Accreditation Program; Two Organizations Achieve Accreditation Following Beta Participation

June 9, 2026 9:00 AM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare technology and data exchange through standards, accreditation, and other services, today launched its Artificial Intelligence (AI) v1.0 Accreditation Program and recognized D.A.W. Systems and ZeOmega as the first organizations to achieve Foundational accreditation, and Inpriva as a Candidate for Comprehensive accreditation, following participation...

Read more

CVS Health Recognized for Technology That Improves Medication Safety and Patient Care

June 9, 2026 9:00 AM

CVS Health The company was awarded a 2026 Newsweek AI Impact Award Originally published on CVS Health Company Newsroom CVS Health® (NYSE:CVS) announced it has been recognized by Newsweek with the 2026 AI Impact Award in the AI Health Care category, specifically for Best Outcomes - Patient Care. The award recognizes CVS Health's AI-Driven Prescription Interpretation and Instruction Standardization technology, which embeds artificial intelligence...

Read more

Ignite Biomedical and Liquid Biosciences Partner to Discover First-in-Class Drug Targets

June 9, 2026 8:00 AM

Ignite Biomedical, Inc. ("Ignite") and Liquid Biosciences, developer of the Emerge AI platform, today expanded their collaboration into drug-target discovery for new therapeutic development. Mainstream drug-discovery AI tools rely on consensus mining: they train on the published literature and databases, so they can only recombine what is already known. Emerge instead models the causal biology of disease directly from patient data. It discovers...

Read more

UniDoc Connect Surpasses One Million Patient Visits

June 9, 2026 7:30 AM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), an innovator in the eHealth sector, is pleased to announce that UniDoc Connect, the Company's enterprise eHealth platform, has surpassed one million recorded patient visits. Key Takeaways: UniDoc Connect has surpassed one million recorded patient visits since UniDoc's March 2025 acquisition of AGNES Connect software and related AMD Telemedicine assets. UniDoc...

Read more

Same-Day Crowns and Advanced Imaging Are Changing Patient Expectations at Dreamtime Dentistry

June 9, 2026 5:00 AM

Why does same-day crown technology matter to patients? Most people expect crowns to take weeks and require at least two appointments. That used to be standard. Now, with in-house CEREC technology, patients can walk in with a damaged tooth and walk out with a permanent crown the same day. "Patients used to ask, 'So I come back in two weeks?' Now, when we tell them it's done the same day, they think we're joking. Then they leave with a permanent...

Read more

Skalar Analytical Streamlines Citation Management and Gains Deeper Analytics Insights with Bioz

June 9, 2026 4:00 AM

Bioz, Inc. the leading platform utilizing research for product validation, announced its collaboration with Skalar Analytical, a member of the Velaris family, which includes more than seven brands and is home to some of the world's leading laboratory automation companies, supported by the global investment firm Battery Ventures. Through the implementation of Bioz Badges, Skalar Analytical is strengthening how scientists discover and engage with...

Read more

Orviglance Data Presented Today at the Annual Radiology Congress ESGAR 2026

June 9, 2026 1:45 AM

Ascelia Pharma AB (publ)(STO:ACE) announces that Orviglance® data will be presented as an oral presentation today at the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Annual Meeting in Montpellier, France. As communicated earlier, the abstract, based on images from two phase 2 studies, demonstrated that Orviglance significantly improves the detection of focal liver lesions compared to unenhanced MRI, underlining its...

Read more